期刊文献+

富来汀联合灭吐灵对肿瘤化疗期间呕吐疗效及护理分析

下载PDF
导出
摘要 目的探讨富来汀联合灭吐灵治疗肿瘤化疗期间呕吐的临床疗效及护理方法。方法选取肿瘤化疗期间呕吐患者180例,随机分为观察组与对照组,观察组于化疗前0.5h及化疗后6h采用富来汀8mg静注,灭吐灵20mg肌注,连用5d,对照组单用灭吐灵治疗,对比两组治疗效果,并探讨其护理方法。结果观察组止吐疗效优于对照组,组间比较差异有统计学意义(P<0.05)。结论富来汀联合灭吐灵是治疗肿瘤化疗期间呕吐的有效方案。
出处 《河北北方学院学报(自然科学版)》 2013年第4期80-81,共2页 Journal of Hebei North University:Natural Science Edition
  • 相关文献

参考文献5

二级参考文献27

  • 1郑伟华,饶珈琦,谢德荣,詹锋,张华.H_2受体拮抗剂用于抑制由化疗引起的恶心呕吐的临床研究[J].肿瘤防治杂志,2004,11(11):1203-1205. 被引量:5
  • 2[1]Tan M. Granisetron: new issights into its use for the treatmentof chemotherapy - induced nausee, and vomiting [ J ]. ExpertOpin Pharmacother, 2003, 4(9): 1 563.
  • 3[2]Youlten L. The effect of repeat dosing with cimetidine on thepharmacokinetics of intravenous granisetron in healthyvolunteers[J] . J Pharm Pharmncol , 2004,56(2): 169.
  • 4[3]Thongprasert S. Efficacy and tolerability of tropisetron in theprevention of cisplatin - induced nausea and vomiting inadvanced non- small cell lung cancer[ J]. Acta 0ncol,2000,39,221.
  • 5[4]Kelley SP, Hodge CW. The 5 - HT3 antagonist Y - 25130blocks cocaine - induced lowering of ICSS reward thresholds inthe rat[J] . Pharmacol Biochem Behav, 20031 74(2) :297.
  • 6[5]Eisenberg P, MacKintosh FR, Ritch P, et al. Efficacy,safety and pharmacokinetics of palonosetron in patientsreceiving highly emetogenic cisplatin - based chemotherapy: adose- ranging clinical study[J]. Med Lett Drugs Ther ,2004,46(1 179) :27.
  • 7[6]Anonymous. Palonosetron(Aloxi) for prevention of nausea andvomiting due to cancer chemotherapy [ J ]. Med Lea DrugsTher ,2004,46( 1 179) :28.
  • 8[7]Grunberg SM, Koeller JM. Palonosetron:a unique 5 - HT3 -receptor antagonist for the prevention of chemotherapy -induced emesis[J]. Expert Opin Pharmacother, 2003,4( 12):2 297.
  • 9[8]Eisenberg P, MacKintosh FR, Ritch P, et al.Efficacy, safetyand pharmacokinetics of palonosetron in patients receivinghighly emetogenic cisplatin - based chemotherapy: a dose -ranging clinical study[J] .Ann Oncol, 2004, 15(2):330.
  • 10[9]Gralla R, Lichinitser M, VanDerVegt S, et al. Palonosetronimproves prevention of chemotherapy - induced nausea andvomiting following moderately emetogenic chemotherapy:results of a double - blind randomized phase ~I trialcomparing single doses of palonosetron with ondansetron [ J ] .Ann Oncol,2003, 14(10): 1 570.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部